A method for ligand screening by automated nano-electrospray ionization mass spectrometry (nano-ESI/MS) is described. The core of the system consisted of a chip-based platform for automated sample delivery from a 96-well plate and subsequent analysis based on noncovalent interactions. Human fatty acid binding protein, H-FABP (heart) and A-FABP (adipose), with small potential ligands was analyzed. The technique has been compared with a previously reported method based on nuclear magnetic resonance (NMR), and excellent coorelation with the found hits was obtained. In the current MS screening method, the cycle time per sample was 1.1 min, which is approximately 50 times faster than NMR for single compounds and approximately 5 times faster for compound mixtures. High reproducibility was achieved, and the protein consumption was in the range of 88 to 100 picomoles per sample. Futhermore, a novel protocol for preparation of A-FABP without the natural ligand is presented. The described screening approach is suitable for ligand screening very early in the drug discovery process before conventional high-throughput screens (HTS) are developed and/or used as a secondary screening for ligands identified by HTS. (Journal of Biomolecular Screening 2003:247-256)
References
1.
1. Westerfeld JG: Detection trends in high throughput screening . Anal Bioanal Chem2002;372: 43-43 .
2.
2. Goodnow RA Jr: Current practices in generation of small molecule new leads . J Cell Biochem Suppl2001;37: 13-21 .
3.
3. Wilm MS, Mann M: Electrospray and Taylor-cone theory, Doles beam of macromolecules at last . Int J Mass Spectrom Ion Processes1994;136: 167-180 .
4.
4. Rogniaux H, Van Dorsselaer A, Barth P, Biellmann JF, Barbanton J, van Zandt M, et al: Binding of aldose reductase inhibitors: correlation of crystallographic and mass spectrometric studies . J Am Soc Mass Spectrom1999;10: 635-647 .
5.
5. Ganem B, Li YT, Henion JD: Detecting of noncovalent receptor-ligand complexes by mass spectrometry . J Am Chem Soc1991;113: 6294-6296 .
6.
6. Smith RD, Light-Wahl KJ: The observation of non-covalent interactions in solution by electrospray ionization mass spectrometry: promise, pitfalls and prognosis . Biol Mass Spectrom1993;22: 493-501 .
7.
7. Nesatyy VJ: Mass spectrometry evaluation of the solution and gas-phase binding properties of noncovalent protein complexes . Int J Mass Spectrom2002;221: 147-161 .
8.
8. Gabelica V, Vreuls C, Filée P, Duval V, Joris B, De Pauw EJ: Advantages and drawbacks of nanospray for studying noncovalent protein-DNA complexes by mass spectrometry . Rapid Commun Mass Spectrom2002;16: 1723-1728 .
9.
9. Siegel MM: Early discovery drug screening using mass spectrometry . Curr Topics Med Chem2002;2: 13-33 .
10.
10. Sannes-Lowery KA, Drader JJ, Griffey RH, Hofstadler SA: Fourier transform ion cyclotron resonance mass spectrometry as a high throughput affinity screen to identify RNA binding ligands . Trends Anal Chem2000;19: 481-491 .
11.
11. Wigger M, Eyler JR, Benner SA, Li W, Marshall AG: Fourier transform-ion cyclotron resonance mass spectrometric resolution, identification, and screening of non-covalent complexes of Hck Src homology 2 domain receptor and ligands from a 324-member peptide combinatorial library . J Am Soc Mass Spectrom2002;13: 1162-1169 .
12.
12. Lyubarskaya YV, Carr SA, Dunnington D, Prichett WP, Fisher SM, Appelbaum ER, et al: Screening for high-affinity ligands to the Src SH2 domain using capillary isoelectric focusing-electrospray ionization ion trap mass spectrometry . Anal Chem1998;70: 4761-4770 .
13.
13. Greig MJ, Robinson JM: Detection of oligonucleotide-ligand complexes by ESI-MS (DOLCE-MS) as a component of high throughput screening . J Biomol Screen2002;5: 441-454 .
14.
14. Jiang Y, Wang PC, Locascio LE, Lee CS: Integrated plastic microfluidic devices with ESI-MS for drug screening and residue analysis . Anal Chem2001;73: 2048-2053 .
15.
15. Hayasaka Y, Asenstorfer REJ: Screening for potential pigments derived from anthocyanins in red wine using nanoelectrospray tandem mass spectrometry . Agric Food Chem2002;50: 756-761 .
16.
16. Glatz JF, van der Vusse GJ: Cellular fatty acid-binding proteins: their function and physiological significance . Prog Lipid Res1996;35: 243-282 .
17.
17. Hotamisligil GS, Johnson RS, Distel RJ, Ellis R, Papaioannou VE, Spiegelman BM: Uncoupling of obesity from insulin resistance through a targeted mutation in aP2, the adipocyte fatty acid binding protein . Science1996;274: 1377-1379 .
18.
18. Zimmerman AW, Veerkamp JH: New insights into the structure and function of fatty acid-binding proteins . Cell Mol Life Sci2002;59: 1096-1116 .
19.
19. Tahallah N, Pinkse M, Maier CS, Heck AJR: The effect of the source pressure on the abundance of ions of noncovalent protein assemblies in an electrospray ionization orthogonal time-of-flight instrument . Rapid Commun Mass Spectrom2001;15: 596-601 .
20.
20. Benkestock K, Edlund PO, Roeraade J: On-line microdialysis for enhanced resolution and sensitivity during electrospray mass spectrometry of non-covalent complexes and competitive binding studies . Rapid Commun Mass Spectrom2002;16: 2054-2059 .
21.
21. Constantine KL, Friedrichs MS, Wittekind M, Jamil H, Chu CH, Parker RA, et al: Backbone and side chain dynamics of uncomplexed human adipocyte and muscle fatty acid-binding proteins . Biochem1998;37: 7965-7980 .
22.
22. Schnutgen F, Borchers T, Muller T, Spener F: Heterologous expression and characterisation of mouse brain fatty acid binding protein . Biol Chem Hoppe-Seyler1996;377: 211-215 .
23.
23. van Dongen MJP, Uppenberg J, Svensson S, Lundbäck T, Åkerud T, Wikström M, et al: Structure-based screening as applied to human FABP4: a highly efficient alternative to HTS for hit generation . J Am Chem Soc2002;124: 11874-11880 .
24.
24. Diercks T, Coles M, Kessler H: Applications of NMR in drug discovery . Curr Opin Chem Biol2001;5: 285-291 .
25.
25. Hajduk PJ, Gerfin T, Boehlen JM, Haberli M, Marek D, Fesik SW: High-throughput nuclear magnetic resonance-based screening . J Med Chem1999;42: 2315-2317 .
26.
26. Robinson CV, Chung EW, Kragelund BB, Knudsen J, Aplin RT, Poulsen FM, et al: Probing the nature of noncovalent interactions by mass spectrometry: a study of protein-CoA ligand binding and assembly . J Am Chem Soc1996;118: 8646-8653 .
27.
27. Van Pelt CK, Zhang S, Henion JD: Characterization of a fully automated nanoelectrospray system with mass spectrometeric detection for proteomic analyses . J Biomol Techn2002;13: 72-84 .
28.
28. Daniel JM, Friess SD, Rajagopalan S, Wendt S, Zenobi R: Quantitative determination of noncovalent binding interactions using soft ionization mass spectrometry . Int J Mass Spectrom2002;216: 1-27 .
29.
29. van Breemen RB, Huang CR, Nikolic D, Woodbury CP, Zhao YZ, Venton DL: Pulsed ultrafiltration mass spectrometry: a new method for screening combinatiorial libraries . Anal Chem1997;69: 2159-2164 .
30.
30. Liu C, Wu Q, Harms AC, Smith RD: On-line microdialysis sample cleanup for electrospray ionization mass spectrometry of nucleic acid samples . Anal Chem1996;68: 3295-3299 .
31.
31. Jorgensen TJD, Hvelplund P, Andersen JU, Roepstorff P: Tandem mass spectrometry of specific vs. nonspecific noncovalent complexes of vancomycin antibiotics and peptide ligands . Int J Mass Spectrom2002;219: 659-670 .
32.
32. Zimmerman AW, van Moerkerk HT, Veerkamp JH: Ligand specificity and conformational stability of human fatty acid-binding proteins . Int J Biochem Cell Biol2001;33: 865-876 .
